Trials / Active Not Recruiting
Active Not RecruitingNCT06389513
Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants
Phase IV Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 3,011 (actual)
- Sponsor
- CanSino Biologics Inc. · Industry
- Sex
- All
- Age
- 3 Months – 3 Months
- Healthy volunteers
- Accepted
Summary
This study is an open, multicenter Phase IV clinical study to evaluate the safety of vaccination with Menhycia®. The study plan is to enroll approximately 3,000 infants at 3 months of age who have not been vaccinated with any epidemic encephalitis vaccine, and to administer a total of 3 doses of Menhycia®, with a minimum of 1 month between doses, and a booster dose of 1 dose of immunization is allowed at 12 months of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MCV4 | 4 doses of vaccine on Day 0, Day30, Day 60 and Month 12 |
Timeline
- Start date
- 2024-06-12
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2024-04-29
- Last updated
- 2025-08-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06389513. Inclusion in this directory is not an endorsement.